YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
Current Neuropharmacology - United Arab Emirates
doi 10.2174/1570159x15666170208124324
Full Text
Open PDFAbstract
Available in full text
Date
July 31, 2017
Authors
Publisher
Bentham Science Publishers Ltd.